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a b s t r a c t
Secreted infectious particles generated by the genotype 2a JFH-1 hepatitis C virus infectious clone are
resistant to acidic pH, whereas intracellular virions remain acid-labile. Thus, JFH-1 particles are thought to
undergo pH maturation as they are secreted from the cell. Here, we demonstrate that both infectious
intracellular and secreted genotype 1a (H77)/JFH-1 chimaeric particles display enhanced acid sensitivity
compared with JFH-1, although pH maturation still occurs upon release. Introduction of p7 sequences from
genotype 1a infected HCV patients into the H77/JFH-1 background yielded variable effects on infectious
particle production and sensitivity to small molecule inhibitors. However, two selected patient p7 sequences
increased the acid stability of secreted, but not intracellular H77/JFH-1 particles, suggesting that p7 directly
inﬂuences particle pH maturation via an as yet undeﬁned mechanism. We propose that HCV particles vary in
acid stability, and that this may be dictated by variations in both canonical structural proteins and p7.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Hepatitis C virus (HCV) infects over 170 million individuals,
causing severe liver disease and hepatocellular carcinoma. Despite
the development of infectious HCV culture over recent years, the
processes underpinning infectious particle production are poorly
understood and the properties of infectious particles are yet to be
fully characterised. Studies of genotype 2a JFH-1 HCV revealed
intracellular particles to be acid-labile, whereas secreted particles
are resistant to transient pH reductions following release from the
cell (Tscherne et al., 2006; Wozniak et al., 2010). Thus, virion pH
maturation is thought to occur during/following secretion, coun-
teracting the fusogenic effects of reduced pH on particle-
associated glycoproteins (Haid et al., 2009; Lavillette et al.,
2006). pH maturation is subsequently reversed during productive
virus entry (Tscherne et al., 2006), yet the mechanisms under-
pinning this process are unclear and the acid sensitivity of other
HCV isolates has not been established.
Several HCV proteins contribute to infectious virion production
in addition to canonical core and envelope (E1/2) glycoproteins.
Amongst these, the 63 amino acid integral membrane protein, p7,
performs at least two essential functions, namely: interactions
with HCV NS2 that target it to hypothetical sites of virion
morphogenesis (Boson et al., 2011; Jirasko et al., 2008; Jirasko
et al., 2010; Ma et al., 2011; Popescu et al., 2011; Stapleford and
Lindenbach, 2011; Tedbury et al., 2011), as well as oligomerisation
to form membrane channel complexes (Grifﬁn et al., 2003;
Pavlovic et al., 2003; Premkumar et al., 2004). p7 channel activity
within cells can equilibrate proton gradients and potentially
protect acid-labile intracellular particles within acidifying secre-
tory vesicles (Wozniak et al., 2010). p7 channel function is there-
fore reminiscent of inﬂuenza A virus M2, which can also protect
the haemagglutinin (HA) glycoprotein (Steinhauer et al., 1991)
from reduced pH during secretion. Accordingly, p7 and M2 proton
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channel activity appear functionally interchangeable (Bentham
et al., 2013; Grifﬁn et al., 2004; Wozniak et al., 2010).
Previous studies indicated that genotype 1a p7 channels (H77
isolate) displayed characteristics reminiscent of a non-selective
membrane pore in vitro (Li et al., 2012). This contrasts both with
M2 and genotype 1b p7 (Li et al., 2012; StGelais et al., 2007) (J4
isolate), which behave as acid-activated channels with unidirectional
conductance. This altered behaviour for genotype 1a p7 channels led
us to investigate whether virion maturation may be affected in
chimaeric genotype 1a cell culture systems (H77/JFH-1). Here, we
show that H77/JFH-1 particles display greater sensitivity to acidic pH
compared with JFH-1, yet they still appear to undergo maturation
upon release. However, introduction of p7 sequences isolated from
genotype 1a infected patients into the H77/JFH-1 backbone can
signiﬁcantly affect the acid stability of secreted particles, suggesting
that p7 may exert a direct inﬂuence over the pH maturation process.
Results
H77/JFH-1 particles display enhanced acid sensitivity compared
with JFH-1
We investigated whether particles comprising genotype 1a
structural proteins (H77/JFH-1 chimaera) differed in their acid
sensitivity compared with genotype 2a JFH-1 particles. Virions
from intracellular and secreted compartments were transiently
exposed to either neutral or reduced pH, then neutralised prior to
determining residual infectivity (Fig. 1a). Infectivity of intracellular
H77/JFH-1 particles was signiﬁcantly diminished by relatively mild
pH reductions (e.g. from pH 7.0 down to pH 6.0), whereas JFH-1
intracellular infectivity was stable until more stringent pH condi-
tions were applied (Fig. 1a, left panel). Furthermore, as seen
previously (Wozniak et al., 2010), secreted JFH-1 infectivity
remained largely unaffected by transient pH reductions with
80% of infectivity remaining at pH 4.0, indicative of virion
maturation having occurred (Fig. 1a, middle panel). By contrast,
secreted H77/JFH-1 infectivity was again signiﬁcantly reduced at
mildly acidic pH. However, comparison of the ratio of residual
infectivity in both secreted and intracellular compartments
revealed that a degree of pH maturation had still occurred for
H77/JFH-1, despite the overall increase in acid sensitivity (Fig. 1a,
right panel). Importantly, these characteristics were not due to the
overall integrity of H77/JFH-1 particles, as they retained near-
identical thermal stability compared with JFH-1 (Fig. 1b).
JFH-1 p7 forms an M2-like channel in vitro
We tested whether JFH-1 p7 displayed in vitro channel char-
acteristics similar to either H77 p7, or to M2/genotype 1b p7.
Previous studies have shown that liposome dye release assays
robustly discriminate between M2-like channels (e.g. J4 p7)
activated by reduced external pH (pHext) relative to the liposome
interior, and pore-like channels (e.g. H77 p7), which are activated
by shifting electrochemical gradients in either direction (Li et al.,
2012; StGelais et al., 2007). As a positive control, peptides
representing the conductance domain of pandemic H1N1 “swine”
inﬂuenza A virus M2 were assessed for activation upon reduced
pHext. In agreement with its well characterised gating mechanism
(Pinto et al., 1997), M2 channels increased in activity upon reduced
pHext, conﬁrming that liposome dye release assay could reliably
recapitulate channel gating behaviours observed in other systems
(Fig. 1c). Comparison of JFH-1 p7 with the H77 protein, which
behaved in a pore-like fashion as reported previously (Li et al.,
2012), revealed JFH-1 p7 activity to be strongly activated by
reduced pHext, indeed to an even greater extent than the M2
positive control (Fig. 1c).
Characterising the effects of genotype 1a patient isolate p7 sequences
in the H77/JFH-1 background
As H77/JFH-1 and JFH-1 differed both with respect to p7
channel gating behaviour and virion acid stability, we hypothe-
sised that altering p7 channel gating in an H77/JFH-1 context
might have consequences for both the production of infectious
H77/JFH-1 particles, as well as their pH maturation. Whilst multi-
ple mutations have been identiﬁed that affect p7 function, these
often have complex phenotypes which, combined with a lack of
information regarding p7 gating mechanisms, makes them an
unreliable means of manipulating channel behaviour. However,
we previously identiﬁed a series of genotype 1a p7 sequences from
patient isolates (Fig. 2a) that displayed variable activity and gating
patterns in vitro (Li et al., 2012), providing a means to alter p7
behaviour in the H77/JFH-1 backbone using isogeneic proteins that
are functional in an in vivo context.
Comparison of infectious titres generated by H77/JFH-1 and
JFH-1 over time revealed a similar level of infectivity, although this
was reduced at late times (72 h post-transfection) in the H77/JFH-
1 secreted compartment (Fig. 2b). Introduction of patient derived
p7 sequences had variable effects on infectivity, although both
pore-like (M2_1; S2_167; S3_175; S3_180) and M2-like (M1_4;
S1_1) variants (Li et al., 2012) resulted in detectable titres (Fig. 2b).
Two variants displayed either a mild (M2_1) or severe (S1_1)
reduction of infectivity in both intracellular and secreted compart-
ments. This appeared independent of their displaying pore- or M2-
like activity respectively as another M2-like variant (M1_4) pro-
duced infectious virus to the same degree as parental H77/JFH-1.
The S3_180 variant showed only a very mild particle infectivity
defect at later times, which was unexpected as the variant
contained a mutation at one of the highly conserved basic residues
in the p7 loop region. The S2_167 variant was the only one found
to cause an increase in secreted infectivity, although this effect was
only 3-fold. Analysis of viral protein production revealed no
apparent disruption to polyprotein processing, although the
abundance of variant p7 proteins varied (Fig. 2c). However,
reduced/increased p7 abundance did not correlate with particle
infectivity, as described recently for JFH-1 p7 carrying alanine
substitutions (Bentham et al., 2013). As differences in infectious
particle production did not seemingly depend on whether p7
sequences displayed either pore-like or M2-like behaviour, three
were taken forward for further characterisation, namely: M1_4
and S1_1 (M2-like) and S2_167 (pore-like).
Sensitivity of patient variant sequences to small molecule p7 channel
inhibitors
Genotype 1a H77 p7 displays a high level of resistance to
adamantane p7 inhibitors (Grifﬁn et al., 2008; Steinmann et al.,
2007) which bind to a peripheral binding site on the membrane
exposed face of the channel complex (Foster et al., 2013; Foster
et al., 2011; OuYang et al., 2013), and likely stabilise the closed
form of the channel complex. As H77 displays extensive sequence
similarity to sensitive GT1b channels, we hypothesised that
natural variation associated with switching from pore- to M2-
like behaviour might inﬂuence susceptibility to this class of
antivirals. Secreted infectivity was therefore assessed at 72 h post
transfection in the presence of the adamantane drug, rimantadine,
or the alkylated imino-sugar NN-DNJ, which acts via a different
mechanism disrupting the formation of oligomeric complexes
(Foster et al., 2011) (Fig. 3). Parental H77/JFH-1, JFH-1, and
H77/JFH-1 harbouring variant p7 sequences were all susceptible
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to NN-DNJ. By contrast, whilst H77/JFH-1, M1_4 and S2_167
remained insensitive to increasing concentrations of rimantadine,
the S1_1 variant displayed sensitivity comparable with JFH-1,
which is considered to be a rimantadine sensitive genotype
(Foster et al., 2011; Gottwein et al., 2011).
pH maturation of secreted genotype 1a particles is inﬂuenced
by patient-derived p7 variants
Finally, we characterised the acid sensitivity of three H77/JFH-1
clones carrying patient variant p7 sequences. Intracellular infec-
tivity from all three patient p7 variants retained acid stability
similar to prototypic H77/JFH-1, although S2_167 displayed inter-
mediate sensitivity at pH 6.2 (Fig. 4, top panels). By contrast,
analysis of secreted infectivity revealed signiﬁcant differences
between particles produced by H77/JFH-1 harbouring patient p7
variants and the parental clone. In all three cases, sensitivity to
mild pH reductions (pH 6.0, 5.0) mirrored that of JFH-1 particles
rather than H77/JFH-1 (Fig. 4, bottom panels) and this trend
continued in for the M2-like variants (M1_4 and S1_1) at the
lowest pH (pH 4.0). S2_167 variant particles displayed an inter-
mediate sensitivity to pH 4.0, signiﬁcantly different from either
JFH-1 or H77/JFH-1 parental clones. Comparison of the ratios of
intracellular and secreted infectivity revealed that the maturation
of viruses carrying the S1_1 and S2_167 p7 variants was more
efﬁcient. As this ratiometric shift was a result primarily of changes
in the pH sensitivity of secreted, but not intracellular particles, we
conclude that p7 exerts a direct inﬂuence over the particle pH
maturation process.
Discussion
This work demonstrates that HCV particles comprising geno-
type 1a (H77) structural proteins differ from those assembled by
the parental genotype 2a JFH-1 clone with respect to acid
sensitivity, yet their ability to switch from an acid-labile, to a
more acid-stable phenotype upon release from the infected cell
appears intact. This process, referred to as “pH-maturation” is
speciﬁc to the effects of reduced pH rather than the overall
integrity of particles, based on similar thermal stability. Further-
more, the effects of introducing patient isolate p7 sequences
supports that acid stability and pH maturation are inﬂuenced by
Fig. 1. Enhanced acid sensitivity of genotype 1a HCV particles. Virions were harvested 72 h post-electroporation with either genotype 2a (JFH-1) or chimeric genotype 1a/2a
(H77/JFH-1: “HJ3-5”) and subjected to varied acid or thermal environments. (A) Virions were mixed 1:1 with HEPES/MES buffers to give ﬁnal pH ranging from 7.4 down to
5.2 and incubated at 37 1C for 10 min. Conditions were neutralised using NaOH and residual infectivity determined by focus forming assay. Results are the average of three
independent experiments, error bars represent standard error of the mean. Results are normalised to the untreated value as 100% for comparison. Right panel shows the ratio
of residual secreted and intracellular infectivity at a given pH. (B) Clariﬁed infectious JFH-1 and H77/JFH-1 supernatants were aliquotted and incubated at 56 1C for increasing
time, then placed on ice prior to focus forming assays. Results are the average of three experimental repeats with error bars representing standard error. Results are
normalised to the untreated value as 100% for comparison. (C) Comparison of H77 and JFH-1 pH activated channel activity alongside a positive control M2 peptide. Effects of
altering external pH (pHext) relative to the liposome interior (pH 6.8) were assessed. Activity was normalised to a positive control genotype 1b (J4 isolate) protein at pHext 7.4
(100%, not shown). Results are the average of two independent experiments with triplicate repeats of each condition. Error bars represent standard error (N.B. some small
error bars are occluded by data points, e.g. M2; JFH-1 p7 at pH 6.2 and 6.8).
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both canonical structural proteins as well as the p7 sequence
encoded by the virus.
The mechanisms underpinning the acid sensitivity of intracellular
HCV particles are likely speciﬁc to the envelope glycoproteins,
as these are known to undergo fusogenic change in response to
low pH (Haid et al., 2009; Lavillette et al., 2006). Analogous to certain
strains of inﬂuenza A virus, exposure to reduced pH as secretory
vesicles become acidiﬁed via the action of vATPase would be
expected to induce premature membrane fusion and so prevent
efﬁcient secretion of infectious particles. One potential role for p7
channel complexes within the membranes of secretory vesicles is
therefore to prevent the build-up of proton gradients (Wozniak et al.,
2010). The majority of intracellular infectious HCV virions reside
within the ER in Huh7 cells (Gastaminza et al., 2008) so they are not
Fig. 2. Characterisation of H77/JFH-1 carrying patient variant p7 sequences. Full length constructs were derived containing genotype 1a patient p7 sequences. Growth
characteristics and protein expression were assessed following electroporation of Huh7 cells. (A) Sequences of patient isolates compared to parental H77 and JFH-1 p7
sequences. Bold indicates mutations present within patient variants compared with H77 and major, non-synonymous changes are shown on the right hand side. (B) Time
course of secreted (top panels) and intracellular infectivity determined by focus forming assay. Controls comprised wild type JFH-1, H77/JFH-1 and JFH-1 carrying the
GDD4GND mutation in the NS5B active site (“GND”). Results are the average of three experimental repeats with error bars representing standard error. (C) HCV protein
expression was determined within cell lysates, a representative series of immunoblots is shown comparing patient isolates with controls.
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exposed to reduced pH, making the dependence upon p7 proton
channel function likely to be a late stage of infectious particle
production. Accordingly, small molecule p7 inhibitors only prevent
the accumulation of secreted infectivity and do not affect intracellular
levels (Foster et al., 2013; Foster et al., 2011), presumably as titres are
largely conferred by the ER-resident pool. Presumably, intracellular
particles exposed to reduced pH in the absence of p7 function are
degraded, likely via a proteasome independent mechanism
(Gastaminza et al., 2008), which could be linked to activation of
the unfolded protein response by HCV glycoproteins (Mohl et al.,
2012). However, p7 also plays additional roles at early points during
particle production that are likely independent of channel function
(Boson et al., 2011; Gentzsch et al., 2013; Jirasko et al., 2008; Jirasko
et al., 2010; Ma et al., 2011; Popescu et al., 2011; Stapleford and
Lindenbach, 2011; Tedbury et al., 2011). The reduction in intracellular
and secreted infectivity observed for H77/JFH-1 carrying the M2_1
and S1_1 p7 variants could therefore arise due to defects in one or
both of these functions.
It is tempting to speculate that envelope glycoprotein and p7
sequences may co-evolve such that pore-like channels accompany
more acid-labile glycoproteins and vice versa. This appears to hold
true for H77, where the pore-like activity of its p7 protein would
instantly dissipate the accumulation of protons. Similarly, the
more robust JFH-1 particles are associated with an acid-activated,
M2-like channel, which presumably allows for a degree of vesicle
acidiﬁcation to occur prior to activation. Thus, incompatible
combinations of p7 and envelope proteins, i.e. acid labile glyco-
proteins and an M2-like p7, might be expected to signiﬁcantly
reduce infectious titres. However, whilst this hypothesis held for
the S1_1 M2-like variant p7 in the H77 background which reduced
titres, it was not borne out by M1_4, which is also M2-like in vitro.
Thus, it is possible that S1_1 polymorphisms also affect p7
functions in addition to its channel activity in the H77/JFH-1
context. Nevertheless, it would be of signiﬁcant interest to
investigate potential genetic linkages between p7 and envelope
sequences in patient cohorts.
The mechanisms underpinning the pH-maturation from acid-
labile intracellular to stable secreted virions are unclear. Interest-
ingly, secreted JFH-1 virions are largely resistant to transient pH
reductions yet prolonged exposure to acidic conditions at 37 1C
results in their inactivation (Tscherne et al., 2006). This suggests
that energy is required to overcome a feature of secreted particles
that otherwise prevents protons from permanently destroying
infectivity. The effects of reduced pH on HCV glycoproteins were
recently shown to be mediated via conserved histidine residues
within E2 (Boo et al., 2012), suggesting that conformational
changes resulting from side chain ionisation is responsible. pH
maturation may therefore involve either structural rearrange-
ments of the virion itself, or interactions with factors that prevent
the acidiﬁcation of the particle. Either of these possibilities may
account for the shift in particle density observed between intra-
cellular and secreted particles (Gastaminza et al., 2006), with
lipoprotein interactions providing an obvious candidate. Interest-
ingly, the acid sensitivity of JFH-1 particles in the present study
differed to that observed previously (Wozniak et al., 2010), with
lesser sensitivity to mild pH changes. Our method herein utilised
virions concentrated and partially-puriﬁed through a sucrose
cushion and resuspended in PBS, rather than harvested directly
in complete medium. We hypothesise that (lipo)-proteins or other
serum/cellular components co-puriﬁed and concentrated through
the sucrose cushion may affect the acid sensitivity of puriﬁed
particles. However, we have not performed a direct comparison as
the buffering of media and PBS is also different, the latter requiring
mixing with less acidic HEPES/MES buffers to reach a given pH
(see Materials and methods and (Wozniak et al., 2010)).
What is not clear is how altering the p7 sequence might
inﬂuence the stability of secreted virions. It is possible that p7
variants may differentially mediate the trafﬁcking of particles
through cellular compartments where pH-maturation may, or
may not take place. Alternatively, p7-protein interactions may
alter the recruitment of various chaperones, glycosidases or other
modiﬁers of protein structure that might mediate the transition
from pH-immature to mature particles during egress. However,
both of these possibilities are related to pH solely affecting the
glycoprotein components of virions, yet evidence exists to suggest
that acidiﬁcation may be required to mediate stages of productive
virus entry in addition to glycoprotein fusion. Speciﬁcally, a
protonation-mimetic mutant of a conserved E2 histidine involved
in pH response (H445R) important for the entry process, was
unable to overcome baﬁlomycin A (bafA) blockade of virus entry
(Boo et al., 2012). In another study, citrate was only able to
promote the infection of bafA treated cells following prolonged
incubation at 37 1C, suggesting that processes additional to glyco-
protein fusogenic changes are involved (Tscherne et al., 2006).
Fig. 3. Inﬂuence of patient polymorphisms on p7 inhibitor sensitivity. Huh7 cells electroporated with selected H77/JFH-1 containing patient p7 sequences were subjected to
treatment with prototype allosteric (rimantadine) and oligomerisation (NN-DNJ) p7 inhibitors at increasing concentrations. Secreted infectivity was determined at 48 h post-
electroporation by focus forming assay. Parental H77/JFH-1 and JFH-1 served as controls. Left hand side, rimantadine sensitivity and right hand side shows sensitivity of all
variants and controls to NN-DNJ. Results are the average of two separate experiments with triplicate wells and are normalised to solvent only controls (DMSO) at 100% for
comparison. Error bars represent standard error of the mean between experiments.
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This study ruled out a role for endosomal cathepsins, implicating
additional features of the virion particle. One possibility is that the
nucleocapsid core may require acidiﬁcation in order to promote
efﬁcient uncoating of the RNA, which may be mediated by a
stoichiometrically small number of p7 channel complexes present
within the virion membrane. However, recent studies of epitope-
tagged p7 provided no evidence of the protein being present
within the virion (Vieyres et al., 2013), although it is not clear
whether glycoproteins might obscure antibody access to under-
lying channel complexes. Another study found no defects in
speciﬁc infectivity to be present in low titre particles generated
by a J6/JFH-1 chimaera carrying a mutation of the p7 dibasic loop
region. However, such mutations may disrupt p7 membrane
insertion rather than channel activity (Bentham et al., 2013;
Perez-Berna et al., 2008; StGelais et al., 2009), making it possible
that functional channel complexes existed within mutant parti-
cles. Furthermore, as both p7 inhibitor studies (Grifﬁn et al., 2008)
and the uptake of HCV-like particles by hepatocytes (Saunier et al.,
2003) functionally support a role for p7 during entry, more
detailed analysis will be necessary to determine conclusively
whether p7 channel complexes exist within particles and regulate
their acid sensitivity.
Taken together, our studies show that acidic pH plays a vital
role in the egress and stability of infectious HCV particles. This
appears likely to vary both between genotypes as well as at the
level of individual virus variants within the p7 protein.
Materials and methods
Plasmid constructs
Constructs for glutathione-S-transferase (GST) fusions of GT1a
H77 and patient p7 sequences were described (Li et al., 2012). Full
length constructs were based on GT2a JFH-1 (Wakita et al., 2005),
including the GT1a chimera, pHJ3-5 (Yi et al., 2007), encoding core
Fig. 4. Inﬂuence of patient polymorphisms on secreted virion maturation and p7 inhibitor sensitivity. Intracellular and secreted virions from Huh7 cells electroporated with
H77/JFH-1 containing patient variants (dark lines) were tested for acid sensitivity as in Fig. 1. Results from triplicate experiments were normalised to untreated (100%) and
compared with parental H77/JFH-1 and JFH-1 controls (lighter grey lines). Error bars represent standard errors and asterisks indicate the incidence of statistically signiﬁcant
differences (student T test, *pr0.05, **pr0.01) between patient variants and parental controls.
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to NS2 of HCV H77. Patient p7 sequences were ampliﬁed from
cDNA using speciﬁc primers, and introduced into pHJ3-5 digested
with MauBI (Fermentas) and AfeI (New England Biolabs). Details
and primer sequences are available upon request.
Analysis of recombinant p7 channel activity
FLAG-tagged p7 was expressed, cleaved from GST, and puriﬁed by
rHPLC as described (Clarke et al., 2006; Foster et al., 2011; StGelais
et al., 2007). M2 conductance domain (aa 18–60) peptides of
pandemic “swine” inﬂuenza A virus H1N1 (A/pH1N1), incorporating
an N31S mutation, were obtained from Peptides International Inc.,
(Louisville, KY, USA). Sequence: RCSDSSDPLVIAASIIGILHLILWITD-
RLFFKCIYRRFKYGLK-NH2. Liposome dye release assays for pH depen-
dent channel activity were conducted as described (Li et al., 2012;
StGelais et al., 2007; Wetherill et al., 2012).
HCV culture
Huh7 cells were cultured, transfected and treated with Riman-
tadine (Chembridge) and NN-DNJ (Toronto Biochemicals) as
described (Grifﬁn et al., 2008). Time course experiments divided
single electroporations (8106 cells) amongst three T25 ﬂasks
(Corning) in 5 ml of HEPES-buffered (pH 7.4) DMEM, with cells/
media harvested every 24 h. Infectivity was determined by focus
forming assays (Grifﬁn et al., 2008).
Virion pH sensitivity
Particle acid sensitivity was assessed using a method adapted
from Wozniak et al. (2010). HEPES/MES buffers (20 mM HEPES,
20 mM MES, 133.5 mM NaCl, 2 mM CaCl2, 4 mM KCl, 1.2 mM
MgSO4, 11 mM glucose) were prepared to pH 3.3, pH 3.9,
pH 6.0 and pH 7.4, to yield ﬁnal pH values of 4.0, 5.2, 6.2 and
7.4 when mixed 1:1 (v/v) with PBS (pH 7.4). Clariﬁed supernatants
were harvested and concentrated through a PBS/20% w/v sucrose
cushion at 150,000 g, 4 1C for 4 h in a Sorvall AH650 rotor.
Intracellular virus was prepared by freeze-thaw lysis (3) of
harvested cells in PBS, followed by removal of cell debris by
centrifugation at 1000 g for 5 min at room temperature in a
microfuge. Puriﬁed virus stocks were mixed 1:1 with HEPES/MES
buffers as above, then incubated for 10 min at 37 1C. Acidic pH was
neutralised by an appropriate volume of 1 M NaOH. Residual
infectivity was determined by focus forming assay.
Virion temperature sensitivity
Clariﬁed supernatants were harvested 48 h post-transfection,
aliquotted, and then placed in awater bath at 54 1C. Triplicate samples
were removed at each time point and placed immediately on ice prior
to determining residual infectivity by focus forming assay.
Protein analysis
Total cell lysates in enriched broth culture (EBC) lysis buffer
containing 0.5% NP40 and 0.1% SDS were generated from T25
ﬂasks as described (Grifﬁn et al., 2008). Immunoblots were
performed using mouse monoclonal anti-E2 antibody (AP33),
rabbit anti-core polyclonal serum (R4128), rabbit anti-NS2 poly-
clonal serum, sheep anti-NS5A polyclonal serum, mouse mono-
clonal anti-glyceraldehyde phosphate dehydrogenase (GAPDH;
6C1, Abcam) and rabbit anti-p7 polyclonal serum 2716 (Foster
et al., 2011; Grifﬁn et al., 2008; Luik et al., 2009; StGelais et al.,
2009) puriﬁed and concentrated on a protein G column. 2716 is
speciﬁc to the JFH-1 p7 N-terminus and is weakly cross-reactive
with GT1a.
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